SUBSCRIBE
SUBSCRIBE
Genetown

Alnylam Pharmaceuticals To Webcast Presentation At Upcoming Investor Conferences

November 1, 2006 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at two investor conferences on Tuesday, November 7, 2006:
Events
Alnylam Pharmaceuticals
MORE ON THIS TOPIC
People raise their hands. Leadership fights. The concept of fighting for rights. Revolution or protest. vector
Pancreatic cancer
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer
June 25, 2026
 · 
2 min read
 · 
Tristan Manalac
From left to right: Lowell Zeta, acting chief of staff and deputy commissioner; Karim Mikhail, acting CBER director; Michael Davis, acting CDER director; John Crowley, president and CEO of BIO
Policy
FDA hiring 2,200 people to staff up after last year’s DOGE cuts
June 24, 2026
 · 
3 min read
 · 
Jef Akst
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
 · 
1 min read
 · 
Jef Akst
John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), on the main stage at the 2026 BIO International Convention in San Diego
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
June 24, 2026
 · 
2 min read
 · 
Annalee Armstrong